151 related articles for article (PubMed ID: 10945919)
1. An area correction method to reduce intrasubject variability in bioequivalence studies.
Abdallah HY
J Pharm Pharm Sci; 1998; 1(2):60-5. PubMed ID: 10945919
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
[TBL] [Abstract][Full Text] [Related]
3. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R
Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.
Karalis V; Symillides M; Macheras P
Eur J Pharm Sci; 2009 Aug; 38(1):55-63. PubMed ID: 19524039
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
7. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics.
Fernández-Teruel C; Gonzalez-Alvarez I; Navarro-Fontestad C; García-Arieta A; Bermejo M; Casabó VG
Eur J Pharm Sci; 2009 Jan; 36(1):147-56. PubMed ID: 19038335
[TBL] [Abstract][Full Text] [Related]
8. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives.
Endrenyi L; Tothfalusi L
Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors in human bioequivalence study that incur bioinequivalence of oral drug products.
Yamashita S; Tachiki H
Mol Pharm; 2009; 6(1):48-59. PubMed ID: 19049413
[TBL] [Abstract][Full Text] [Related]
12. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study.
Dos Reis Serra CH; Mori Koono EE; Kano EK; Schramm SG; Armando YP; Porta V
Clin Ther; 2008 May; 30(5):902-8. PubMed ID: 18555936
[TBL] [Abstract][Full Text] [Related]
14. Assessment of selection bias in estimates of relative bioavailability and intrasubject variability from bioequivalence evaluations.
Wang Y
J Biopharm Stat; 2000 Aug; 10(3):407-24. PubMed ID: 10959920
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Intra- and Intersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products.
Sugihara M; Takeuchi S; Sugita M; Higaki K; Kataoka M; Yamashita S
Mol Pharm; 2015 Dec; 12(12):4405-13. PubMed ID: 26568266
[TBL] [Abstract][Full Text] [Related]
16. Limitations of Levothyroxine Bioequivalence Evaluation: Analysis of An Attempted Study.
Mayor GH; Orlando T; Kurtz NM
Am J Ther; 1995 Jun; 2(6):417-432. PubMed ID: 11850687
[TBL] [Abstract][Full Text] [Related]
17. Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.
Endrenyi L; Fritsch S; Yan W
Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):394-9. PubMed ID: 1748540
[TBL] [Abstract][Full Text] [Related]
18. Disparity in intestine disposition between formed and preformed metabolites and implications: a theoretical study.
Sun H; Pang KS
Drug Metab Dispos; 2009 Jan; 37(1):187-202. PubMed ID: 18948379
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
20. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
